US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rapport Therapeutics, Inc.

11.33

-0.1400-1.22%

Post-market: 11.330.00000.00%16:05 EDT

Volume:79.81K

Turnover:927.52K

Market Cap:413.50M

PE:-3.00

High:12.31

Open:11.76

Low:11.27

Close:11.47

Loading ...

Overview Company News Filings

Rapport Therapeutics Announces New Phase 1 Data, Further Supporting Rap-219'S Transformative Potential for CNS Disorders

THOMSON REUTERS

Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

Rapport Therapeutics, Inc. (RAPP) Receives a Buy from Jefferies

Companies Like Rapport Therapeutics (NASDAQ:RAPP) Can Afford To Invest In Growth

Simply Wall St.

Rapport Therapeutics management to meet with Truist

Rapport Therapeutics Reports Correlation Between Seizure Biomarker, Clinical Seizures

MT Newswires Live

Rapport Therapeutics presents data on long episode seizure biomarker

Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in Rns Measured Long Episodes and Meaningful Reductions in Clinical Seizures

THOMSON REUTERS

Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures

Two new option listings and one option delisting on November 21st

Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting

Rapport Therapeutics Reports Q3 Financials and Strategic Updates

BRIEF-Rapport Therapeutics Reports Q3 Financials And Provides Business Update

Rapport Therapeutics expects cash to fund requirements through 2026

Rapport Therapeutics adds new members to Board of Directors

Rapport Therapeutics Inc Q3 Shr View $-0.58 -- Lseg Ibes Data

THOMSON REUTERS

Rapport Therapeutics Inc - Qtrly Shr Loss $0.50

THOMSON REUTERS

Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update

Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RAPP/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RAPP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAPP\",,,,,undefined,":{"symbol":"RAPP","market":"US","secType":"STK","nameCN":"Rapport Therapeutics, Inc.","latestPrice":11.33,"timestamp":1746216000000,"preClose":11.47,"halted":0,"volume":79809,"hourTrading":{"tag":"盘后","latestPrice":11.33,"preClose":11.33,"latestTime":"16:05 EDT","volume":681,"amount":7715.7300000000005,"timestamp":1746216310622},"delay":0,"floatShares":14750261,"shares":36496437,"eps":-3.775953,"marketStatus":"Post-Mkt","change":-0.14,"latestTime":"05-02 18:45:55 EDT","open":11.76,"high":12.3101,"low":11.27,"amount":927515.597087,"amplitude":0.09068,"askPrice":14.54,"askSize":100,"bidPrice":8.33,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.775953,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1746230400000},"marketStatusCode":4,"adr":0,"listingDate":1717732800000,"exchange":"NASDAQ","adjPreClose":11.47,"preHourTrading":{"tag":"盘前","latestPrice":11.47,"preClose":11.47,"latestTime":"04:22 EDT","volume":4,"amount":46.32,"timestamp":1746174148162},"postHourTrading":{"tag":"盘后","latestPrice":11.33,"preClose":11.33,"latestTime":"16:05 EDT","volume":681,"amount":7715.7300000000005,"timestamp":1746216310622},"volumeRatio":0.521198,"impliedVol":0.7198,"impliedVolPercentile":0.5545},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAPP\",,,,,undefined,":{"symbol":"RAPP","floatShares":14750261,"roa":"-22.07%","roe":"-35.09%","lyrEps":-3.775953,"volumeRatio":0.521198,"shares":36496437,"dividePrice":0,"high":12.3101,"amplitude":0.09068,"preClose":11.47,"low":11.27,"week52Low":6.43,"pbRate":"1.35","week52High":29.74,"institutionHeld":0,"latestPrice":11.33,"eps":-3.775953,"divideRate":0,"volume":79809,"delay":0,"ttmEps":-3.775953,"open":11.76,"prevYearClose":17.74,"prevWeekClose":10.62,"prevMonthClose":11.45,"prevQuarterClose":10.03,"fiveDayClose":10.62,"twentyDayClose":8.52,"sixtyDayClose":17.55},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RAPP\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2502153950","title":"Rapport Therapeutics Announces New Phase 1 Data, Further Supporting Rap-219'S Transformative Potential for CNS Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2502153950","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502153950?lang=en_us&edition=fundamental","pubTime":"2025-01-09 20:00","pubTimestamp":1736424000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250109:nTUA6FRQX5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RAPP","BK4007"],"gpt_icon":0},{"id":"2502015616","title":"Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2502015616","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502015616?lang=en_us&edition=fundamental","pubTime":"2025-01-09 20:00","pubTimestamp":1736424000,"startTime":"0","endTime":"0","summary":"In the PET trial, RAP-219 achieved and exceeded target receptor occupancy, increasing support for the dosing regimen utilized in the ongoing Phase 2a trial in focal epilepsy; restricted neuroanatomica","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/09/3006949/0/en/Rapport-Therapeutics-Announces-New-Phase-1-Data-Further-Supporting-RAP-219-s-Transformative-Potential-for-CNS-Disorders.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNS","BK4007","BK4192","BK4218","BK4135","ECG","BK4129","PK","LENZ","BK4181","RAPP","PET"],"gpt_icon":0},{"id":"2490396727","title":"Rapport Therapeutics, Inc. (RAPP) Receives a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2490396727","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490396727?lang=en_us&edition=fundamental","pubTime":"2024-12-09 21:26","pubTimestamp":1733750772,"startTime":"0","endTime":"0","summary":"In a report released today, Andrew Tsai from Jefferies maintained a Buy rating on Rapport Therapeutics, Inc. (RAPP – Research Report), with a price...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rapport-therapeutics-inc-rapp-receives-a-buy-from-jefferies?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rapport-therapeutics-inc-rapp-receives-a-buy-from-jefferies?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","RAPP"],"gpt_icon":0},{"id":"2489331276","title":"Companies Like Rapport Therapeutics (NASDAQ:RAPP) Can Afford To Invest In Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2489331276","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489331276?lang=en_us&edition=fundamental","pubTime":"2024-12-07 22:27","pubTimestamp":1733581666,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rapp/rapport-therapeutics/news/companies-like-rapport-therapeutics-nasdaqrapp-can-afford-to","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B3QW5Z07.USD","NDAQ","TQQQ","MNQmain","NQmain","BK4585","RAPP","BK4112","BK4007","QID",".IXIC","LU2210149790.SGD","QLD","BK4588","PSQ","LU2095319765.USD","LU2210150020.SGD","SQQQ","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BKPKM429.USD"],"gpt_icon":1},{"id":"2489250466","title":"Rapport Therapeutics management to meet with Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2489250466","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489250466?lang=en_us&edition=fundamental","pubTime":"2024-12-07 02:45","pubTimestamp":1733510719,"startTime":"0","endTime":"0","summary":"Meeting to be held in Denver on December 17 and in Chicago on December 18 hosted by Truist. Published first on TheFly – the ultimate source for rea...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-management-to-meet-with-truist?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-management-to-meet-with-truist?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","BK4007","RAPP"],"gpt_icon":0},{"id":"2489254279","title":"Rapport Therapeutics Reports Correlation Between Seizure Biomarker, Clinical Seizures","url":"https://stock-news.laohu8.com/highlight/detail?id=2489254279","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489254279?lang=en_us&edition=fundamental","pubTime":"2024-12-07 01:36","pubTimestamp":1733506609,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics  said Friday that data from a proof-of-concept study of RAP-219 showed a link between a seizure biomarker and clinical seizures.The data showed that a 30% reduction in long episode frequency was associated with a decrease of at least 50% in clinical seizures, regardless of the antiseizure medication used, according to the company.This sets the benchmark for evaluating the potential efficacy of antiseizure treatments, including RAP-219, the company said.Price: 20.17, Change: -0.11, Percent Change: -0.52","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","RAPP","LENZ","BK4139"],"gpt_icon":0},{"id":"2489925630","title":"Rapport Therapeutics presents data on long episode seizure biomarker","url":"https://stock-news.laohu8.com/highlight/detail?id=2489925630","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489925630?lang=en_us&edition=fundamental","pubTime":"2024-12-07 01:05","pubTimestamp":1733504756,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics (RAPP) announced it will present “novel findings” on the association between a seizure biomarker used in the company’s proof-o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-presents-data-on-long-episode-seizure-biomarker?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-presents-data-on-long-episode-seizure-biomarker?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RAPP","LENZ","BK4007"],"gpt_icon":0},{"id":"2489255320","title":"Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in Rns Measured Long Episodes and Meaningful Reductions in Clinical Seizures","url":"https://stock-news.laohu8.com/highlight/detail?id=2489255320","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489255320?lang=en_us&edition=fundamental","pubTime":"2024-12-07 01:01","pubTimestamp":1733504469,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241206:nFWN3N71EM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RAPP"],"gpt_icon":0},{"id":"2489556192","title":"Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures","url":"https://stock-news.laohu8.com/highlight/detail?id=2489556192","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489556192?lang=en_us&edition=fundamental","pubTime":"2024-12-07 01:01","pubTimestamp":1733504460,"startTime":"0","endTime":"0","summary":"A 30% reduction in long episodes was shown to be associated with a 50% or greater reduction in clinical seizures in a post-hoc analysis, validating the biomarker for proof-of-concept studies Change in","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/06/2993179/0/en/Rapport-Therapeutics-Presents-Data-Demonstrating-Consistent-Association-Between-Decreases-in-RNS-Measured-Long-Episodes-and-Meaningful-Reductions-in-Clinical-Seizures.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","RAPP"],"gpt_icon":0},{"id":"2485960344","title":"Two new option listings and one option delisting on November 21st","url":"https://stock-news.laohu8.com/highlight/detail?id=2485960344","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485960344?lang=en_us&edition=fundamental","pubTime":"2024-11-21 21:30","pubTimestamp":1732195807,"startTime":"0","endTime":"0","summary":"New option listings for November 21st include PepGen Inc (PEPG) and Rapport Therapeutics Inc (RAPP). Option delistings effective November 21st incl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/two-new-option-listings-and-one-option-delisting-on-november-21st?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/two-new-option-listings-and-one-option-delisting-on-november-21st?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RAPP","BK4139","PEPG","BK4007"],"gpt_icon":0},{"id":"2483876074","title":"Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2483876074","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483876074?lang=en_us&edition=fundamental","pubTime":"2024-11-14 20:00","pubTimestamp":1731585600,"startTime":"0","endTime":"0","summary":"Poster presentations on Phase 2a trial seizure biomarker, preclinical, and Phase 1 clinical dataBOSTON and SAN DIEGO, Nov.  14, 2024  (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/14/2981023/0/en/Rapport-Therapeutics-to-Present-Data-at-American-Epilepsy-Society-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","RAPP","AFG"],"gpt_icon":0},{"id":"2482494112","title":"Rapport Therapeutics Reports Q3 Financials and Strategic Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2482494112","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482494112?lang=en_us&edition=fundamental","pubTime":"2024-11-09 12:28","pubTimestamp":1731126529,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics, Inc. ( ($RAPP) ) has released its Q3 earnings. Here is a breakdown of the information Rapport Therapeutics, Inc. presented to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rapport-therapeutics-reports-q3-financials-and-strategic-updates?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rapport-therapeutics-reports-q3-financials-and-strategic-updates?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","RAPP","BK4007","BK4139"],"gpt_icon":0},{"id":"2481905323","title":"BRIEF-Rapport Therapeutics Reports Q3 Financials And Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2481905323","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481905323?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:21","pubTimestamp":1730982075,"startTime":"0","endTime":"0","summary":"Nov 7  - Rapport Therapeutics Inc   :   * RAPPORT THERAPEUTICS REPORTS THIRD QUARTER FINANCIALS AND PROVIDES BUSINESS UPDATE   * QTRLY LOSS PER SHARE $0.50   * Q3 EARNINGS PER SHARE VIEW $-0.58 -- LSEG IBES DATASource text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2481905557","title":"Rapport Therapeutics expects cash to fund requirements through 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2481905557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481905557?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:18","pubTimestamp":1730981890,"startTime":"0","endTime":"0","summary":"The Company ended the third quarter with $320.7 million in cash, cash equivalents and short-term investments, compared to $336.1 million as of June...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-expects-cash-to-fund-requirements-through-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-expects-cash-to-fund-requirements-through-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","LENZ","RAPP"],"gpt_icon":0},{"id":"2481905897","title":"Rapport Therapeutics adds new members to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2481905897","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481905897?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:17","pubTimestamp":1730981851,"startTime":"0","endTime":"0","summary":"The Company announced the appointment of new members to its Board of Directors to help guide its next phase of growth and innovation, including Rob...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-adds-new-members-to-board-of-directors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-adds-new-members-to-board-of-directors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","RAPP","LENZ"],"gpt_icon":0},{"id":"2481903123","title":"Rapport Therapeutics Inc  Q3 Shr View $-0.58 -- Lseg Ibes Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2481903123","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481903123?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:00","pubTimestamp":1730980805,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUA28MJGX:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RAPP","BK4007"],"gpt_icon":0},{"id":"2481184903","title":"Rapport Therapeutics Inc - Qtrly Shr Loss $0.50","url":"https://stock-news.laohu8.com/highlight/detail?id=2481184903","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481184903?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:00","pubTimestamp":1730980805,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUA28MJGX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RAPP"],"gpt_icon":0},{"id":"2481903422","title":"Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2481903422","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481903422?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:00","pubTimestamp":1730980800,"startTime":"0","endTime":"0","summary":"Biotech industry leaders added to the Board of Directors, bringing deep expertise in drug discovery, neuroscience clinical development, and operational leadership. RAP-219 MAD-2 and PET trials ongoing; topline data expected in Q1 2025. Actively recruiting patients for Phase 2a trial of RAP-219 in focal epilepsy; trial on track and topline data expected in mid-2025. Investigational New Drug Application  in diabetic peripheral neuropathic pain placed on clinical hold while the Company addresses U.S. Food and Drug Administration  Phase 2a trial protocol feedback. Ended the quarter with $320.7 million in cash, cash equivalents, and short-term investments, excluding restricted cash, which is expected to fund operations through the end of 2026. BOSTON and SAN DIEGO, Nov. 07, 2024  -- Rapport Therapeutics, Inc. , a clinical-stage biotechnology company focused on discovery and development of small molecule precision medicines for patients suffering from central nervous system  disorders, today","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/uMMULlMfbmwhtRtxiuErJQ--~B/aD0yMDY5O3c9NDA3MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/bcfc377a473266a995d9d5593aaa95d7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/uMMULlMfbmwhtRtxiuErJQ--~B/aD0yMDY5O3c9NDA3MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/bcfc377a473266a995d9d5593aaa95d7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rapport-therapeutics-reports-third-quarter-120000028.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B19Z9Z06.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BK4567","IE00B894F039.SGD","BK4188","LU0256863811.USD","LU2237438978.USD","BK4023","VERX","ASM","IE00B2B36J28.USD","LU0289739699.SGD","BK4532","BK4135","LU0079474960.USD","BK4588","PET","LU1093756168.USD","LU0061475181.USD","IE00BFTCPJ56.SGD","LU2362541273.HKD","BK4585","RAPP","CNS","LU0417517546.SGD","LU1430594728.SGD","LU2362540622.SGD","VRTX","LU1585245621.USD","LU2417539215.USD","LU0889565916.HKD","IE00B19Z3B42.SGD","LU2362541513.USD","LU2456880835.USD","LU0823416689.USD","BK4139","LU0058720904.USD","IE00B19Z9P08.USD","IE00BZ9MQY76.HKD","LU2462157665.USD","IE00B19Z3581.USD","LU1093756325.SGD","LU0109394709.USD","BK4192","LU2324357040.USD","BK4007","LENZ","LU1069344957.HKD","LU2236285917.USD"],"gpt_icon":0},{"id":"2480230102","title":"Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November","url":"https://stock-news.laohu8.com/highlight/detail?id=2480230102","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480230102?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:00","pubTimestamp":1730721600,"startTime":"0","endTime":"0","summary":"BOSTON and SAN DIEGO, Nov.  04, 2024  (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of small molecule preci","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/04/2973884/0/en/Rapport-Therapeutics-to-Present-at-Stifel-Healthcare-Conference-and-Jefferies-London-Healthcare-Conference-in-November.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","LENZ","BK4137","BK4127","BK4135","RAPP","SF","BK4139","HCSG","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":39,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RAPP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-11","symbol":"RAPP","fiscalQuarterEnding":"2024/12","expectedEps":-0.62,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"pre","actualEps":-0.57},{"market":"US","date":"2024-11-07","symbol":"RAPP","fiscalQuarterEnding":"2024/09","expectedEps":-0.57,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RAPP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RAPP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1744171200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RAPP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RAPP","date":"2025-05-01","current":-5.336486,"percent":0.786408,"low":-18.456468,"twenty":-13.67328,"median":-10.644772,"eighty":-5.303861,"high":-1.238107,"avg":-10.019266,"sd":4.102114,"marketCap":417884203},"quantilePoints":[{"date":"2024-06-07","current":-11.721364,"twenty":-11.721364,"median":-11.721364,"eighty":-11.721364,"marketCap":601399769},{"date":"2024-06-14","current":-15.892791,"twenty":-16.325792,"median":-15.672154,"eighty":-13.81742,"marketCap":815427333},{"date":"2024-06-21","current":-15.811683,"twenty":-18.036085,"median":-15.892791,"eighty":-15.139866,"marketCap":811265816},{"date":"2024-06-28","current":-16.346343,"twenty":-18.021611,"median":-15.892791,"eighty":-15.672154,"marketCap":838698159},{"date":"2024-07-05","current":-16.610109,"twenty":-18.028848,"median":-16.581593,"eighty":-15.672154,"marketCap":852231448},{"date":"2024-07-12","current":-18.456468,"twenty":-18.064817,"median":-16.682383,"eighty":-15.783777,"marketCap":946964471},{"date":"2024-07-15","current":-18.299635,"twenty":-18.092899,"median":-16.754656,"eighty":-15.811683,"marketCap":938917651},{"date":"2024-08-02","current":-14.614044,"twenty":-18.085878,"median":-16.682383,"eighty":-15.70006,"marketCap":749817368},{"date":"2024-08-09","current":-10.772462,"twenty":-18.050559,"median":-16.581593,"eighty":-14.719551,"marketCap":678859041},{"date":"2024-08-16","current":-11.828814,"twenty":-17.877609,"median":-15.852237,"eighty":-12.152035,"marketCap":745428193},{"date":"2024-08-23","current":-12.310557,"twenty":-17.253126,"median":-15.672154,"eighty":-12.113216,"marketCap":775786652},{"date":"2024-08-30","current":-11.492174,"twenty":-17.046391,"median":-14.856424,"eighty":-11.831136,"marketCap":724213848},{"date":"2024-09-06","current":-12.316361,"twenty":-16.995064,"median":-14.477739,"eighty":-11.828814,"marketCap":776152417},{"date":"2024-09-13","current":-10.975607,"twenty":-16.754656,"median":-13.041877,"eighty":-11.712731,"marketCap":691660801},{"date":"2024-09-20","current":-11.75336,"twenty":-16.610109,"median":-12.73716,"eighty":-11.45735,"marketCap":740673254},{"date":"2024-09-27","current":-11.915876,"twenty":-16.610109,"median":-12.415031,"eighty":-11.492174,"marketCap":750914662},{"date":"2024-10-04","current":-10.644772,"twenty":-16.581593,"median":-12.319263,"eighty":-11.45735,"marketCap":670812221},{"date":"2024-10-11","current":-11.846226,"twenty":-16.346343,"median":-12.304752,"eighty":-11.439937,"marketCap":746525487},{"date":"2024-10-18","current":-16.28058,"twenty":-16.346343,"median":-12.319263,"eighty":-11.45735,"marketCap":1025969618},{"date":"2024-10-25","current":-14.411651,"twenty":-16.28058,"median":-12.415031,"eighty":-11.492174,"marketCap":908193427},{"date":"2024-10-31","current":-15.578281,"twenty":-15.970349,"median":-12.705237,"eighty":-11.650047,"marketCap":981712105},{"date":"2024-11-08","current":-13.694662,"twenty":-15.827905,"median":-12.870655,"eighty":-11.708088,"marketCap":983906693},{"date":"2024-11-15","current":-11.189913,"twenty":-15.754653,"median":-12.798103,"eighty":-11.650047,"marketCap":803950524},{"date":"2024-11-22","current":-11.464825,"twenty":-15.685802,"median":-12.664608,"eighty":-11.434133,"marketCap":823701811},{"date":"2024-11-29","current":-11.627735,"twenty":-15.672154,"median":-12.397619,"eighty":-11.395825,"marketCap":835406277},{"date":"2024-12-06","current":-10.319361,"twenty":-15.61583,"median":-12.322165,"eighty":-11.357915,"marketCap":741404783},{"date":"2024-12-13","current":-9.677901,"twenty":-15.33799,"median":-12.307654,"eighty":-11.16344,"marketCap":695318447},{"date":"2024-12-20","current":-9.092441,"twenty":-15.121845,"median":-12.218286,"eighty":-11.007144,"marketCap":653255522},{"date":"2024-12-27","current":-9.815356,"twenty":-15.075412,"median":-12.095804,"eighty":-10.933817,"marketCap":705194090},{"date":"2025-01-03","current":-9.362262,"twenty":-15.053587,"median":-12.072587,"eighty":-10.78291,"marketCap":672641044},{"date":"2025-01-10","current":-8.4968,"twenty":-15.021085,"median":-11.886855,"eighty":-10.451725,"marketCap":610461067},{"date":"2025-01-17","current":-6.368782,"twenty":-15.009476,"median":-11.834618,"eighty":-10.309179,"marketCap":457571477},{"date":"2025-01-24","current":-7.264789,"twenty":-14.781954,"median":-11.796891,"eighty":-9.793974,"marketCap":521946041},{"date":"2025-01-31","current":-8.476436,"twenty":-14.660068,"median":-11.755009,"eighty":-9.580154,"marketCap":608998009},{"date":"2025-02-07","current":-8.527345,"twenty":-14.639173,"median":-11.73446,"eighty":-9.397898,"marketCap":612655654},{"date":"2025-02-14","current":-8.028432,"twenty":-14.630244,"median":-11.689515,"eighty":-9.145387,"marketCap":576810726},{"date":"2025-02-21","current":-6.618238,"twenty":-14.619747,"median":-11.627735,"eighty":-9.042041,"marketCap":475493941},{"date":"2025-02-28","current":-5.467683,"twenty":-14.492608,"median":-11.461087,"eighty":-8.488654,"marketCap":392831148},{"date":"2025-03-07","current":-4.11349,"twenty":-14.373344,"median":-11.410917,"eighty":-8.297234,"marketCap":295537772},{"date":"2025-03-14","current":-4.670008,"twenty":-14.343983,"median":-11.35537,"eighty":-8.022323,"marketCap":365694298},{"date":"2025-03-21","current":-4.716615,"twenty":-14.310432,"median":-11.296823,"eighty":-7.313662,"marketCap":369343942},{"date":"2025-03-28","current":-4.520866,"twenty":-14.209667,"median":-11.0932,"eighty":-7.051987,"marketCap":354015438},{"date":"2025-04-04","current":-3.970905,"twenty":-14.097067,"median":-11.027844,"eighty":-6.777076,"marketCap":310949643},{"date":"2025-04-11","current":-4.022172,"twenty":-13.848651,"median":-10.975607,"eighty":-6.460419,"marketCap":314964251},{"date":"2025-04-17","current":-4.54883,"twenty":-13.703476,"median":-10.88248,"eighty":-6.145798,"marketCap":356205225},{"date":"2025-04-25","current":-5.173362,"twenty":-13.694662,"median":-10.772462,"eighty":-5.351373,"marketCap":405110450},{"date":"2025-05-01","current":-5.336486,"twenty":-13.67328,"median":-10.644772,"eighty":-5.303861,"marketCap":417884203}],"updateTime":1746190971880}}}